It has been shown that when mast cells are co‐cultured with bladder cancer cells, CCL2 expression is elevated (after ERβ decrease) and EMT is activated in cancer cells, which express MMP‐9 and display enhanced invasive properties. The gene discussed is ESR2; the disease is urinary bladder carcinoma.